Year |
Citation |
Score |
2019 |
Guest E, Yoo B, Kostadinov R, Farooqi MS, Farrow E, Gibson M, Miller N, Shah K, Pastinen T, Brown PA. Single Cell Sequencing Reveals Heterogeneity of Gene Expression in KMT2A Rearranged Infant ALL at Relapse Compared to Diagnosis Blood. 134: 2756-2756. DOI: 10.1182/Blood-2019-131999 |
0.379 |
|
2019 |
Yoo B, Farooqi MS, Kostadinov R, Cheung W, Farrow E, Kelley S, Miller N, Ge B, Gibson M, Brown P, Guest EM, Pastinen T. Abstract 3649: Allelic imbalance in KMT2A-rearranged infant acute lymphoblastic leukemia Cancer Research. 79: 3649-3649. DOI: 10.1158/1538-7445.Am2019-3649 |
0.407 |
|
2018 |
Kostadinov R, Yoo B, Farooqi MS, Kelley S, Guest E, Burke MJ, Wheelan S, Brown P. Whole Genome Bisulfite Sequencing (WGBS) Robustly Measures the Pharmacodynamic Effect of Decitabine/Vorinostat Epigenetic Treatment in Relapsed Pediatric ALL Demonstrating Potent Hypomethylation Associated with Upregulation of PRC2 and TP53 Targets Blood. 132: 918-918. DOI: 10.1182/Blood-2018-99-119206 |
0.327 |
|
2016 |
Somarelli JA, Ware KE, Kostadinov R, Robinson JM, Amri H, Abu-Asab M, Fourie N, Diogo R, Swofford D, Townsend JP. PhyloOncology: Understanding cancer through phylogenetic analysis. Biochimica Et Biophysica Acta. PMID 27810337 DOI: 10.1016/J.Bbcan.2016.10.006 |
0.374 |
|
2016 |
Kostadinov R, Maley CC, Kuhner MK. Bulk Genotyping of Biopsies Can Create Spurious Evidence for Hetereogeneity in Mutation Content. Plos Computational Biology. 12: e1004413. PMID 27105344 DOI: 10.1371/Journal.Pcbi.1004413 |
0.703 |
|
2016 |
Kuhner MK, Kostadinov R, Reid BJ. Limitations of the driver/passenger model in cancer prevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 26932841 DOI: 10.1158/1940-6207.Capr-15-0343 |
0.702 |
|
2016 |
Cutler J, Tahir R, Kostadinov R, Sekhar R, Huang T, Pandey A, Brown P, Heydarian M, Reddy K. Proteomic/Transcriptomic Signatures of Infant MLL-r Rearranged B-ALL at Diagnosis and Relapse Reveal Lineage Plasticity and Diagnostic Heterogeneity Blood. 128: 2697-2697. DOI: 10.1182/Blood.V128.22.2697.2697 |
0.345 |
|
2016 |
Kostadinov R, Farooqi M, Yoo B, Farrow E, Kelley S, Gibson M, Miller N, Guest EM, Brown P. Landscape of Somatic Mutations and Gene Expression Changes in Relapsed Infant MLL-Rearranged Acute Lymphoblastic Leukemia Blood. 128: 1735-1735. DOI: 10.1182/Blood.V128.22.1735.1735 |
0.482 |
|
2015 |
Kostadinov R, Scharpf R, Brown P. Identifying Subclonal Epigenetic Changes Driving Chemoresistance in Infant MLL-r Acute Lymphoblastic Leukemias Blood. 126: 809-809. DOI: 10.1182/Blood.V126.23.809.809 |
0.383 |
|
2014 |
Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK, Maley CC, Self SG, Vaughan TL, Blount PL, Reid BJ. Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prevention Research (Philadelphia, Pa.). 7: 114-27. PMID 24253313 DOI: 10.1158/1940-6207.Capr-13-0289 |
0.702 |
|
2014 |
Kostadinov R, Scharpf R, Sabunciyan S, Magoon D, Irizarry R, Brown P. Identifying Methylation Changes Driving Evolution of Relapse in MLL-Rearranged Acute Lymphoblastic Leukemias Blood. 124: 3797-3797. DOI: 10.1182/Blood.V124.21.3797.3797 |
0.553 |
|
2013 |
Kostadinov RL, Kuhner MK, Li X, Sanchez CA, Galipeau PC, Paulson TG, Sather CL, Srivastava A, Odze RD, Blount PL, Vaughan TL, Reid BJ, Maley CC. NSAIDs modulate clonal evolution in Barrett's esophagus. Plos Genetics. 9: e1003553. PMID 23785299 DOI: 10.1371/Journal.Pgen.1003553 |
0.697 |
|
2012 |
Schafer ES, Kostadinov R, Murakami P, Negi SS, Figueroa ME, Melnick A, Brown P. Lineage, Fusion Partner and Age Differences in the Methylome of MLL-r Leukemias Blood. 120: 3506-3506. DOI: 10.1182/Blood.V120.21.3506.3506 |
0.328 |
|
2011 |
Martens EA, Kostadinov R, Maley CC, Hallatschek O. Spatial structure increases the waiting time for cancer. New Journal of Physics. 13. PMID 22707911 DOI: 10.1088/1367-2630/13/11/115014 |
0.624 |
|
2011 |
Reid BJ, Kostadinov R, Maley CC. New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3512-9. PMID 21498395 DOI: 10.1158/1078-0432.Ccr-09-2358 |
0.585 |
|
2010 |
Lai LA, Kostadinov R, Barrett MT, Peiffer DA, Pokholok D, Odze R, Sanchez CA, Maley CC, Reid BJ, Gunderson KL, Rabinovitch PS. Deletion at fragile sites is a common and early event in Barrett's esophagus. Molecular Cancer Research : McR. 8: 1084-94. PMID 20647332 DOI: 10.1158/1541-7786.Mcr-09-0529 |
0.597 |
|
2010 |
Kostadinov R, Sprouffske K, Merlo L, Kuhner M, Maley C. Abstract 101: The mechanism of clonal expansion determines the tempo and mode of neoplastic progression in Barrett's esophagus Cancer Research. 70: 101-101. DOI: 10.1158/1538-7445.Am10-101 |
0.651 |
|
Show low-probability matches. |